This study is testing a new blood test called TheraSure CNI-Monitor for people with advanced lung cancer (NSCLC) who are receiving immunotherapy. The test looks for tiny bits of tumor DNA in the blood to see if the cancer is responding to treatment. Researchers want to know if th…
Sponsor: Karsten Gavenis • Aim: Diagnosis
Last updated May 18, 2026 12:07 UTC